Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-23

FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

The FDA approved a supplemental application for diltiazem hydrochloride from Zydus Pharmaceuticals USA Inc., approving a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diltiazem hydrochloride (Diltiazem hydrochloride)

Snippet

SUPPL AP for DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)